CYTOMX THERAPEUTICS INC. - COMMON STOCK
0,9775
25-ноября-24 14:15:55
15 мин. задержка
Акции
+0,0875
+9,83%
Сегодняшний диапазон
0,8900 - 0,9950
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
CytomX Therapeutics to Report Third Quarter 2023 Financial Results on November 7, 2023
31 окт 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
30 окт 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
18 окт 2023 16:30:00 Источник Nasdaq GlobeNewswire
-
CytomX Therapeutics to Present at Upcoming September Investor Conferences
05 сен 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
CytomX Therapeutics to Present at the H.C. Wainwright Immune Cell Engager Virtual Conference
10 авг 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
CytomX Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
08 авг 2023 16:15:00 Источник Nasdaq GlobeNewswire
-
CytomX Therapeutics to Report Second Quarter 2023 Financial Results on August 8, 2023
01 авг 2023 08:00:02 Источник Nasdaq GlobeNewswire
-
CytomX Therapeutics Announces New Employment Inducement Grants
20 июл 2023 09:00:00 Источник Nasdaq GlobeNewswire
-
CytomX Therapeutics Appoints Yu-Waye (Wayne) Chu, M.D., as Chief Medical Officer
17 июл 2023 08:00:01 Источник Nasdaq GlobeNewswire
-
CytomX Therapeutics Announces $30 Million Private Placement from BVF Partners L.P.
30 июн 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
CytomX Therapeutics to Present at the Jefferies Healthcare Conference
01 июн 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
CytomX Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
09 май 2023 16:15:00 Источник Nasdaq GlobeNewswire
-
CytomX Therapeutics to Report First Quarter 2023 Financial Results on May 9, 2023
01 май 2023 16:01:00 Источник Nasdaq GlobeNewswire
-
CytomX Therapeutics to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ
25 апр 2023 16:05:01 Источник Nasdaq GlobeNewswire
-
CytomX Therapeutics Reports Full Year 2022 Financial Results and Provides Business Update
27 мар 2023 16:15:00 Источник Nasdaq GlobeNewswire
-
CytomX Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on March 27, 2023
22 мар 2023 19:23:33 Источник Nasdaq GlobeNewswire
-
CytomX Therapeutics to Present at Upcoming March Investor Conferences
28 фев 2023 16:05:01 Источник Nasdaq GlobeNewswire
-
26 янв 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
17 янв 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
CytomX Therapeutics Provides Business Update and Outlines 2023 Company Priorities
05 янв 2023 16:05:00 Источник Nasdaq GlobeNewswire